Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[EX Q]: Paragraph: "This is the only of the five stories to actually put a dollar figure on the classes. ""Even the cost of a class, which can top $50 a month, is modest compared with the cost of many medications. And unlike drugs, tai chi had no harmful side effects, she says."" Unlike the AP story, which made the mistake of saying that ""symptoms improved significantly for the tai chi group and little for the others,"" this story, at least, presents some numbers. The trouble is, those numbers are in relative terms. So, instead of saying that three months after the classes ended, 27 patients who took tai chi classes felt better and 17 who tried other therapies also felt better, it presents the difference as 82% versus 53%. That seems more dramatic. Absolute data would be more meaningful. Why make the reader do the math? The story is one of the few stories that covered this study to actually point out that ""unlike drugs, tai chi had no harmful side effects."" In the end, because of the comments from Gloria Yeh, the story puts the appropriate caveats on the findings. This sentence does a great job of summarizing some of the problems with the study: ""Yeh notes that researchers don’t know which aspects of tai chi were most helpful: the exercise, deep breathing, relaxation exercise, meeting new friends or learning from a charismatic teacher."" This story actually spends too little time talking about the condition itself. The AP devoted a whole paragraph in an eight paragaph story to the condition, and the LA Times led its piece by describing the disease. USA Today instead went with a very nice description of tai chi, putting the emphasis on the beauty and simiplicity of the therapy rather than the difficulty clinicians have had correctly diagnosing and treating fibromyalgia. This is the only story to include the phrase ""white crane spreads its wings"" or anything like that. The story doesn’t actually quote any of the authors and instead quotes two outside experts, one of whom wrote an accompanying editorial. It fails to fully attribute the comments made by ""Callahan."" It appears that the writer means Leigh F. Callahan, who just completed a study of tai chi for arthritis and was quoted by other reporters. (How did this slip through copy editing? Was this a slip-up only in the online version?) But we can’t give credit to an independent source that the story doesn’t adequately identify. The story does not compare the therapy to existing alternatives or even discuss existing alternatives, aside from a passing reference at the very end to medications. This is the only one of the five stories to note that ""A study in 2007 from the National Institutes of Health found that 2.3 million American adults had used tai chi in the past year."" This doesn’t tell you whether tai chi classes are as readily available in Oklahoma as they are in New Mexico, but it does give you a sense of how popular they are. It is unclear from this story whether tai chi has been studied before for other conditions. It has. It also is unclear what fibromyalgia patients now do for therapy. The LA Times, for example, pointed out that patients in the study stopped taking drugs for treatment, for example. The story does not rely on a news release." Claim: Tai chi may ease fibromyalgia pain
[EX A]: "The story does two things better than all the other stories. It puts a dollar figure to the cost of tai chi therapy, and it gives people a better sense of how popular tai chi is. It could have done a better job evaluating the evidence and providing some absolute numbers to help readers decide how seriously to take these results. Why not just give the absolute numbers? How many out of how many? Why make the reader do the math? ""79% of tai chi participants said their symptoms had improved, compared with 39% of those in the educational class…Even three months after the classes ended, 82% of tai chi students still felt better, compared with 53% of the comparison group."" Sure, the denominators are in the story but we shouldn’t need to pull out the calculator to figure out 79% of x, vs. 39% of x."

[EX Q]: Paragraph: Health Minister Olivier Veran told a briefing he could not determine at this stage when the lockdown would end. If the government were to follow the scientific council’s advice, France would remain at a virtual standstill until April 28. A statement by the council, which advises President Emmanuel Macron on the coronavirus crisis, also said the lockdown was the only really efficient strategy at the moment and “needs to be strictly implemented”. Prime Minister Edouard Philippe said on Monday the widespread lockdown in France could last several more weeks and his government was tightening restrictions on daily life even further. Veran also said France would heed World Health Organization recommendations to increase coronavirus testing. Health agency chief Jerome Salomon said later France would soon be able to conduct 10,000 tests a day. Salomon reported 240 new deaths from coronavirus on Tuesday for a total of 1,100, an increase of 28% that made France the fifth nation to cross the 1,000-fatalities threshold after - China, Italy, Iran and Spain. This tally only accounts for people who died in public hospitals, whereas several retirement homes have been reporting deaths in the double digits. Salomon said health authorities would soon be able to tabulate data coming from retirement homes, which will likely trigger a more dramatic increase in registered fatalities. He said the total number of infections in France had risen to 22,300, a 12% jump in 24 hours. Salomon added that 2,516 people were in a serious condition requiring life support, up by 21% from Monday, and that 8,000 hospital beds were now equipped with ventilators. Claim: French coronavirus death toll tops 1,000, lockdown likely to be extended.
[EX A]: France became the fifth country to report more than 1,000 deaths from coronavirus on Tuesday and a government body dealing with the outbreak suggested the national lockdown imposed last week for an initial 15 days should last at least six weeks.

[EX Q]: Paragraph: "The story mentions that 30 capsules of OSR#1 cost $60. It would have been nice had the story also included information about the amount of active ingredient per capsule and the manufacturer’s recommended dosage. This would have allowed readers to make a better calculation as to the financial impact of treatment. This is critical information considering these costs will be borne out of pocket by anyone using OSR #1. The story juxtaposes a light-hearted ""success story"" with information about the industrial uses of OSR #1 for removing toxic heavy metals from contaminated soil. This is a clever way of way of emphasizing that the use of this product is based entirely on anecdote. The story clearly states that there is no credible evidence supporting the efficacy of the product. The harms of this product are impossible to quantify, given that it doesn’t seem to have been studied in humans or in animals. The story notes that other chelating drugs carry ""significant risks"" and ""can strip the body of metals necessary for health."" It would have been nice to see more specifics about what chelators can do, but the story satisfies the critierion. The story states that medical searches turned up no papers about OSR#1, and that the company which makes the product provided no published studies about its use. The story rightly suggests that this total lack of evidence should be deeply troubling. The story doesn’t exaggerate the prevalence or severity of autism, or of the potentially toxic compounds sometimes used to treat it. The story quotes multiple experts on pharmacology and an FDA spokesperson. It also quotes from an interview with Boyd Haley, president of the company which makes OSR #1. It attempted to get a reaction from Kim Stagliano, an OSR #1 proponent, but this effort was not successful. While the story mentions that there other are chelation drugs out there, it could have mentioned that there are educational strategies which can be helpful for children with autism and which have better evidence to support their use. The story states that OSR#1 is, according to the manufacturer’s website, available only through dentists’ or doctors’ offices. It notes, however, that the Tribune was able to buy 30 capsules of the product directly from a compounding pharmacy listed on the site. We are impressed that the Tribune went to these lengths to establish the product’s availability. The story provides a fairly detailed pedigree for OSR #1 and discusses its similarity to other chelation therapies used in the treatment of autism. It also gives credit to blogger Kathleen Seidel for being the first to raise concerns about OSR #1 in her blog, Neurodiversity.com The story is well sourced and is not based on a press release." Claim: Industrial chemical OSR#1 used as autism treatment
[EX A]:
"The product known as OSR #1 contains a chemical originally intended for clean-up of toxic waste at industrial sites. This story by the Chicago Tribune (which was republished by the Los Angeles Times) examines how, despite a total lack of any research on the product in humans, OSR #1 ended up being marketed as a ""dietary supplement"" for children with autism. The story does an especially good job of pointing out the regulatory gaps which can allow risky, poorly researched products to be sold as ""cures"" to desperate parents and caregivers. It’s an example of health journalism doing what it’s supposed to do, and doing it well. Autism is a serious disorder which affects a growing number of children and their families and for which there are few good treatment options. This is a situation ripe for abuse by overzealous advocates and unscrupulous marketers of uNPRoven therapies. As Boyd Haley, president of the company that make the the OSR#1 supplement, puts it: ""There are so many snake oil salesmen out there, it’s just incredible."""